Recombinant Transmembrane Proteins
225 products
225 products
Beta LifeScience’s Recombinant Membrane Protein Platform offers a complete, scientifically robust solution for expressing and stabilizing multi-pass transmembrane proteins—one of the most complex and valuable classes of drug targets. By integrating three complementary expression formats—VLP, Nanodisc, and Detergent micelle—our platform enables soluble production of full-length membrane proteins while preserving their native structure, correct folding, and biological activity.
Each format is purpose-built to support specific research applications:
With these advanced tools, Beta LifeScience empowers researchers and biopharma innovators to accelerate the discovery of next-generation GPCRs, ion channels, transporters, and tumor-associated membrane targets—bridging the gap between structural biology and translational medicine.
Immobilized Biotinylated Human CLDN6 VLP at 5ug/ml on the streptavidin precoated plate. Dose response curve for Anti-CLDN6 Antibody, mFc Tag with the EC50 of 6.5ng/ml determined by ELISA.
Biotinylated Human CLDN6 VLP captured on CM5 Chip via streptavidin can bind Anti-CLDN6 Antibody with an affinity constant of 0.46 nM as determined in SPR assay.
Loaded Biotinylated Human CLDN6 VLP on Streptavidin-Biosensor can bind Anti-CLDN6 Antibody, hFc Tag with an affinity constant of 1.46 nM as determined in BLI assay.
Immobilized Human AZAR Nanodisc, His Tag at 2ug/ml on se plate. Dose response curve for Anti-A2AR Antibody, mF as with the EC50 of 0.15ug/ml determined by ELISA
Human AZAR Nanodisc, His Tag captured on CM5 Chip via Anti-hi: antibody can bind Anti-A2AR Antibody, mFc Tag with an affinits constant of 0.32 nM as determined in SPR assay.
Loaded Anti-A2AR Antibody on Protein A-Biosensor, can bind Human AZAR Nanodisc, His Tag with an affinity constant of 4.44 nM as determined in BLI assay.
Transmembrane proteins play essential roles in many physiological processes, from molecular transport and signal transduction to cell recognition, anchoring, and interprotein communication. When these proteins malfunction, the consequences are directly linked to the onset and progression of numerous diseases. Their central role in cell signaling and disease biology also makes transmembrane proteins some of the most important drug discovery targets—accounting for nearly 50% of all known therapeutic targets.
Despite their importance, transmembrane proteins remain one of the most technically challenging protein classes to work with. Their naturally low expression levels, hydrophobic surfaces, and sensitivity during solubilization or purification can make it difficult to obtain full-length, properly folded, biologically active proteins for research.
Beta LifeScience specializes in overcoming these challenges. We focus on the development and production of multi-pass transmembrane proteins and have built three advanced expression platforms to deliver high-quality, ready-to-use membrane protein reagents for early-stage drug discovery. Our growing portfolio includes multiple clinically relevant families—such as Claudins, GPCRs, and SLC transporters—and features a broad range of high-value research targets:
Tetraspan Proteins (4TM): Claudin18.1 / 18.2, Claudin-6, CD20, CD9
Heptahelical Proteins (7TM): GPRC5D, CXCR4, SSTR2, GLP1R, CCR5, CCR8
We also offer custom expression services for high-purity, high-activity multi-pass transmembrane proteins, supporting antibody discovery, drug screening, mechanistic studies, and translational research.
Transmembrane proteins are integral membrane proteins that span the lipid bilayer and connect the intracellular and extracellular environments. They mediate essential cellular functions, including signal transduction, molecular transport, and communication between cells and their surroundings. Based on the number of transmembrane helices, they are broadly categorized into single-pass and multi-pass proteins.
Common functional classes include:
Receptors: GPCRs, EGFR, VEGFR, TGF-βR
Ion Channels: Calcium, sodium, and chloride channels
Transporters: ABC transporters, GLUT family
Adhesion Molecules: Integrins, Cadherins, Selectins
Immune Checkpoints: PD-1, PD-L1, CTLA-4, CD47
Because transmembrane proteins govern cellular communication, homeostasis, and immune regulation, they have become indispensable in modern drug discovery and therapeutic antibody development.
Although transmembrane proteins make up nearly one-third of the human proteome, their hydrophobic domains and complex architecture make them difficult to express, solubilize, and purify while retaining native structure and activity.
Researchers often face challenges such as:
Difficulty obtaining full-length proteins with correct conformation
Structural disruption during detergent solubilization or purification
Batch-to-batch variability across expression systems
Limited availability of proteins suitable for structural biology, drug screening, or antibody development
To address these obstacles, Beta LifeScience has engineered an integrated R&D and production system designed specifically for multi-pass transmembrane proteins—helping researchers bypass technical limitations and obtain consistent, application-ready results.
With deep expertise in membrane protein engineering, Beta LifeScience delivers recombinant transmembrane proteins that preserve native structure and exhibit reliable biological functionality—tailored for both discovery research and therapeutic development.
Native Structure Retention: Stabilized using biomimetic environments such as VLPs, Nanodiscs, or optimized detergent micelles to maintain correct topology.
Functional Validation: Verified via ELISA, SPR/BLI, ligand-binding assays, and other method-appropriate tests.
High Purity & Low Endotoxin: Purity ≥95%; endotoxin levels <1 EU/µg.
Flexible Format Options: Available in VLP, Nanodisc, and detergent-solubilized formats.
Exceptional Consistency: Standardized HEK293 expression platforms ensure reproducible results across batches.
Custom Engineering: Fully tailored constructs available—including tag type, truncations, mutations, and host cell line choices.
Transmembrane proteins are central to nearly every aspect of biomedical science. Their structural complexity and functional diversity make them powerful tools in drug discovery, cellular biology, and diagnostic development.
More than 60% of approved drugs act on transmembrane proteins—particularly GPCRs, ion channels, and receptor tyrosine kinases. High-quality membrane proteins enable precise drug screening and structure-based design.
Transmembrane receptors drive key signaling pathways. Studying them provides insights into how cells perceive external cues and how these signals become altered in disease.
Cryo-EM and X-ray crystallography rely on stable, full-length membrane proteins. These structures support rational design of engineered receptors, biosensors, and next-generation therapeutics.
Proteins such as PD-L1, HER2, and ACE2 serve as diagnostic markers for cancer, infectious diseases, and immune disorders. High-quality recombinant versions enable assay development and clinical research.
Transmembrane proteins are used to explore cell adhesion, membrane transport, receptor internalization, and targeted drug delivery—including antibody–drug conjugate (ADC) pathways.
A1: We primarily use the HEK293 expression system, ensuring proper protein folding and glycosylation to maintain native conformation and activity.
A2: The VLP platform preserves full-length native conformation and strong immunogenicity; the Detergent platform provides purified monomeric proteins for structural and drug-binding studies; the Nanodisc platform offers near-native bilayer environments ideal for functional and binding assays.
A3: Functional activity is validated through ligand-binding assays, ELISA, and SPR/BLI, with representative assay data provided in the product datasheet.
A4: Yes. We provide custom tag configurations (His, Flag, Fc, etc.), truncations, point mutations, and expression host selection upon request.
A5: We recommend storage at –80°C. For best results, aliquot before use to avoid repeated freeze–thaw cycles.